Alpha Tau Medical Ltd. Research and Development Expense
Alpha Tau Medical Ltd. (DRTS) reported Research and Development Expense of $32.06 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-09
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $32.06M 20-F · filed 2026-03-09 | |
| 2025-06-30 | $14.18M 6-K · filed 2025-08-11 | |
| 2024-12-31 | $27.02M 20-F · filed 2026-03-09 | |
| 2024-06-30 | $13.31M 6-K · filed 2025-08-11 | |
| 2023-12-31 | $26.42M 20-F · filed 2026-03-09 | |
| 2023-06-30 | $12.26M 6-K · filed 2024-08-14 | |
| 2022-12-31 | $20.89M 20-F · filed 2025-03-12 | |
| 2022-06-30 | $10.68M 6-K · filed 2023-08-28 | |
| 2021-12-31 | $11.45M 20-F · filed 2024-03-07 | |
| 2020-12-31 | $7.54M 20-F · filed 2023-03-09 | |
| 2019-12-31 | $6.64M 20-F · filed 2022-03-28 |